Journal of Alzheimer s Disease · 2017 · 62 citations · 11 references
Life SciencesNeurologyNeuroscienceAutoimmunityNeurodegenerationNeuroimmunologyAutoimmune Neurological DisordersGlial PathologyMicroglia BiologyNeurodegenerative DiseasesNeurodegenerative DisordersTau PathologyBasal Ganglia LesionsLocus Coeruleus CircuitsPostmortem Brain ExaminationPostmortem Tissue ExaminationTau HyperphosphorylationTau-associated NeurodegenerationTdp-43 Pathology
A novel neuronal tauopathy, mainly confined to hypothalamus and brainstem tegmentum, has recently been reported in patients with autoantibodies to the neuronal cell-adhesion molecule IgLON5. We describe a patient with anti-IgLON5 syndrome, who presented with dysautonomia and sleep disorder, followed by subacute dementia. Postmortem brain examination disclosed neuronal tau pathology prevailing in the hippocampus, amygdala, and locus coeruleus, in addition to microglial/neuronal TDP-43 pathology, with overexpression of aberrantly phosphorylated forms and neurotoxic truncated fragments, in basal ganglia, nucleus basalis, thalamus, and midbrain. These findings suggest that neurodegeneration in anti-IgLON5 syndrome might also occur via a microglia-triggered non-cell autonomous pathway.
11
Lídia Sabater, Carles Gaig, Ellen Gelpí et al. · The Lancet Neurology · 2014 · 551 citations · Full text
Medicine, Neurology, Psychiatry +14
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome
Weihua Zhao, David R. Beers, Shaughn Bell et al. · Experimental Neurology · 2015 · 242 citations
Neuropathological criteria of anti-IgLON5-related tauopathy
Ellen Gelpí, Romana Höftberger, Francesc Graus et al. · Acta Neuropathologica · 2016 · 239 citations · Full text
Inflammation Induces TDP-43 Mislocalization and Aggregation
Ana Sofia Correia, Priyanka Patel, Kallol Dutta et al. · PLoS ONE · 2015 · 114 citations · Full text